Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

TAS 301

Known as: TAS-301, TAS301 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Ru(ii)-NHC catalyzes α-olefination of 2-oxindoles using diaryl methanols in the absence of an acceptor. A wide array of… 
  • figure 1
  • figure 2
  • figure 3
2003
2003
Abstract 3-Bis(4-Methoxyphenyl)methylene-2-indolinone (TAS-301) is a poorly water-soluble drug showing low oral bioavailability… 
Highly Cited
2002
Highly Cited
2002
The aim of the present study was to improve the solubility and oral bioavailability of a poorly water-soluble drug, 3-bis(4… 
2001
2001
We previously demonstrated that a recently synthesized drug, TAS-301 [3-bis(4-methoxyphenyl)methylene-2-indolinone], inhibited… 
  • figure 1
  • figure 3
  • figure 4
  • figure 5
  • figure 6
2000
2000
The purpose of this study was to determine the efficacy and the possible mechanism of action of a recently synthesized drug, TAS… 
  • table 1
  • figure 1
  • figure 2
  • table 2
  • figure 3
2000
2000
The purpose of this study was to determine the effect of a recently synthesized drug, TAS-301 [3-bis(4-methoxyphenyl)methylene-2… 
1998
1998
The purpose of this study was to determine the efficacy and the possible mechanism of action of a recently synthesized drug, TAS… 
  • figure 1
  • figure 2
  • figure 4
  • figure 3
  • table 1